SINGAPORE, July 7, 2025 /PRNewswire/ -- Nuevocor, a Singapore-headquartered biotechnology company developing cures for cardiomyopathies driven by aberrant mechanobiology, today announced the appointment of Dr. Thierry Abribat to its Board of Directors. Dr. Thierry Abribat is a seasoned...
Read More Details
Finally We wish PressBee provided you with enough information of ( Nuevocor Strengthens Board with Appointment of Thierry Abribat )
Also on site :